Perla Lansang Selected Research

Perla Lansang Research Topics

6	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2022 - 01/2013
3	COVID-19 05/2022 - 11/2020
3	Atopic Dermatitis (Atopic Eczema) 01/2021 - 11/2018
2	Hemangioma (Angioma) 05/2012 - 01/2007
1	Asthma (Bronchial Asthma) 05/2022
1	Chronic Urticaria 05/2022
1	Skin Diseases (Skin Disease) 03/2022
1	Body Weight (Weight, Body) 01/2022
1	Prurigo 10/2021
1	Alopecia Areata 09/2021
1	Eczema 11/2018
1	Pruritus (Itching) 11/2018
1	Eosinophilia 01/2018
1	Rheumatoid Arthritis 07/2014
1	Autoimmune Diseases (Autoimmune Disease) 07/2014
1	Pemphigus (Pemphigus Vulgaris) 07/2014

3	Interleukin-17 (Interleukin 17)IBA 03/2022 - 04/2021
2	Monoclonal AntibodiesIBA 01/2022 - 07/2019
2	dupilumabIBA 01/2022 - 10/2021
1	halobetasol (ulobetasol)FDA LinkGeneric 09/2022
1	tazarotene (Tazorac)FDA Link 09/2022
1	Omalizumab (Xolair)FDA Link 05/2022
1	ixekizumabIBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 09/2021
1	brodalumabIBA 04/2021
1	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	secukinumabIBA 07/2019
1	Prostaglandins AIBA 11/2018
1	Rituximab (Mabthera)FDA Link 07/2014
1	CD20 AntigensIBA 07/2014
1	Propranolol (Inderal)FDA LinkGeneric 05/2012
1	Imiquimod (Aldara)FDA LinkGeneric 01/2007

4	Therapeutics 01/2021 - 01/2007
2	Biological Therapy 01/2021 - 07/2020
1	N95 Respirators 11/2020
1	Aftercare (After-Treatment) 01/2018
1	Phototherapy (Light Therapy) 01/2013
1	Photochemotherapy (Photodynamic Therapy) 01/2013